A blister package for a contact lens is provided. A deformable slider supporting a lens is movable via pull-tab or hinge to lift the contact lens out of a lens well. The deformable slider can include a hinge connected to a flexible peel-away top of the blister package or connected to a pull tab that can be pulled to pull taut the deformable slider. A blister package is also provided that includes a hinged shell having a lateral opening opposite the hinge, and a deformable slider that is folded over onto itself and seals both a top chamber and a bottom chamber. By pulling a tongue of the deformable slider, which extends from the lateral opening, the deformable slider can be removed from the closed shell and the closed shell can be opened enabling access to the contact lens.

A system and method for determining an optimal combination drug product for a particular patient includes a processor that receives patient information and determines an optimal combination drug product based on the received information. A system which can provide information regarding predicted events or pathologies based on received patient information and guidance on subsequent steps to ameliorate, treat or intervent. A drug production device includes a plurality of drug containers, each of which are coupled to a drug dispensing channel. A controller controls the dispensing of drug through each channel, and a combination drug product is produced from the dispensed drugs. A combination drug product includes a plurality of discrete units of a first drug, and a plurality of discrete units of a second drug. A transdermal patch includes a plurality of drug compartments, each containing a quantity of drug product, and a controller for controlling the release of drugs from each compartment. Feedback loop elements can enable iterations to optimized personalized doses.

A container can include a container body with a neck, a lid, a marble positioned in the neck within one or more flexible flanges, a spring, and/or a flexible detent. The neck can include an opening for dispensing content stored within the container. In some embodiments, the container contains a liquid. In some embodiments, the container includes a non-dissolvable membrane that extends from the lower end of the flexible flange(s) below the marble. In some embodiments, at least a portion of the marble is dissolvable in the liquid stored in the container body. In some embodiments, upon the marble dissolving, the liquid content changes color, flavor and/or nutrients are released into the liquid content.

A dosage device that includes a cannabinoid-containing substance enables controlled addition of the cannabinoid-containing substance to a liquid to produce a cannabinoid-containing liquid for ingestion. In an embodiment, such a dosage device is provided with a container that has a container body holding a liquid and a cover to seal the container body. A dosage device may also or instead be provided with a cover that includes a coupling structure to releasably couple the cover to a liquid container and a seal to seal the container. Other embodiments, including methods of use of a container, methods that involve providing a cannabinoid-containing substance and adding the cannabinoid-containing substance to a cover, and product packages that include multiple covers, are also disclosed.

A beverage can with an ingredient chamber for storing functional ingredients separately from a base beverage until the beverage can is opened by a consumer. The ingredient chamber may be disposed on a can end of the beverage can. The ingredient chamber may be broken open to release functional ingredients automatically when the beverage can is opened by the consumer. In some embodiments, the ingredient chamber includes a membrane that forms a sealed cavity. In some embodiments, the ingredient chamber includes a deformed cavity of the can end.

In some embodiments, apparatuses and methods are provided herein useful to dispensers. In some embodiments, a dispenser comprises a main body including an outer wall and an inner wall, the inner wall defining an aperture through the main body; a first seal, wherein the first seal is affixed to the main body and encloses a lower portion of the aperture; a button seated within the aperture and configured to be manipulable between a first position and a second position; a container housed within the button and configured to store a material, wherein when the button is in the second position the container contacts the first seal to allow the material to exit the dispenser; and a second seal, wherein the second seal is affixed to an upper surface of the main body and encloses an upper portion of the aperture.

An apparatus for facilitating dispensing payloads into a container. The apparatus is couplable with an opening of the container and includes a placing element and a dispensing element. The placing element is coupled with the opening, includes first openings fluidly coupled with the opening, and defines payload receptacles around the first openings. The payload receptacles define recesses for receiving payload holders. The payload holders include breakable layers for releasably securing the payloads into the payload holders. The dispensing element is coupled with the placing element, transitions from a first position to a second position based on an external action, and includes a pressing element. The pressing element presses the payload holders based on the transitioning for breaking the breakable layers and releasing the payloads from the payload holders. The payloads pass through the first openings for dispensing the payloads into the container based on the releasing.

A system and method for determining an optimal combination drug product for a particular patient includes a processor that receives patient information and determines an optimal combination drug product based on the received information. A system which can provide information regarding predicted events or pathologies based on received patient information and guidance on subsequent steps to ameliorate, treat or intervent. A drug production device includes a plurality of drug containers, each of which are coupled to a drug dispensing channel. A controller controls the dispensing of drug through each channel, and a combination drug product is produced from the dispensed drugs. A combination drug product includes a plurality of discrete units of a first drug, and a plurality of discrete units of a second drug. A transdermal patch includes a plurality of drug compartments, each containing a quantity of drug product, and a controller for controlling the release of drugs from each compartment. Feedback loop elements can enable iterations to optimized personalized doses.

A blister package for a contact lens is provided. A deformable slider supporting a lens is movable via pull-tab or hinge to lift the contact lens out of a lens well. The deformable slider can include a hinge connected to a flexible peel-away top of the blister package or connected to a pull tab that can be pulled to pull taut the deformable slider. A blister package is also provided that includes a hinged shell having a lateral opening opposite the hinge, and a deformable slider that is folded over onto itself and seals both a top chamber and a bottom chamber. By pulling a tongue of the deformable slider, which extends from the lateral opening, the deformable slider can be removed from the closed shell and the closed shell can be opened enabling access to the contact lens.

One example of a cannabinoid-containing product includes a cannabinoid-containing liquid for ingestion and an additive for production of a cannabinoid-containing aerosol for inhalation. A container for such a product could include a container body holding the cannabinoid-containing liquid and additive, and a cover to seal the container body. Another type of container includes a container body holding contents that include a liquid for ingestion, a cover to seal the container body, and an aerosolizer packaged with the container to aerosolize a cannabinoid from the contents for airborne delivery of a cannabinoid-containing aerosol for inhalation. Other embodiments, including multi-container packages, uses, and methods of use, are also disclosed.